Physician profile
Michael E Potts
NPI 1144278102
$1,088.78
in general payments reported to CMS, 2019-2025
18 companies · $75.97 in 2025
The $75.97 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $27.26 · 2021: $469 · 2022: $144 · 2023: $128 · 2024: $115 · 2025: $75.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $406.69 | 2019-2023 | |
| Hologic Sales and Service, LLC | $118.43 | 2021-2025 | Aptima, Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Janssen Pharmaceuticals, INC | $90.08 | 2021 | |
| Exeltis, USA INC. | $89.46 | 2023-2024 | Slynd |
| Astellas Pharma US INC | $58.86 | 2023-2024 | Veozah |
| Pfizer INC. | $53.87 | 2019-2022 | |
| Organon LLC | $39.71 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.59 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $35.04 | 2020-2024 | Ultomiris |
| Daiichi Sankyo INC. | $26.84 | 2019 | |
| Allergan, INC. | $25.28 | 2019 | |
| Medtronic, INC. | $23.34 | 2023 | Truclear |
| Therapeuticsmd, INC. | $19.60 | 2022 | |
| Lilly USA, LLC | $15.80 | 2023 | Jardiance, Emgality |
| Alfasigma USA, INC. | $15.22 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $15.05 | 2019 | |
| Mylan Pharmaceuticals INC. | $12.47 | 2021 | |
| Kinex Medical Company LLC | $4.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Potts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.